Mitochondrial Abnormalities of T Lymphocytes in Patients With Maintenance Hemodialysis
Immunity, Inflammation and Disease · 2026-03 · 14 (3)
DOI: 10.1002/iid3.70404 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 17.03.2026. Verfasst von Chunlei Luo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Renal Dialysis, Mitochondria, T-Lymphocyte Subsets, Kidney Failure, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Science and Technology Project of Zhejiang Province, Key Research and Development Program of Ningbo.
Abstract (Originalsprache)
Objective
To investigate the characteristics of T lymphocyte subsets and mitochondrial function in hemodialysis patients and to explore the effect of hemodialysis on these parameters.
Methods
Patients with end‐stage renal disease (ESRD) from July 2023 to June 2024, who underwent mitochondrial function detection of T lymphocyte subsets, were included in this retrospective study. Patients were categorized into a hemodialysis group and a pre‐dialysis group based on whether they received hemodialysis. The hemodialysis group was further divided into those with dialysis duration ≤ 12 months and those with > 12 months. Peripheral blood from ESRD patients was analyzed by flow cytometry to obtain data on T lymphocyte subsets, mitochondrial mass (MM), and low mitochondrial membrane potential (MMP‐Low). Differences in T lymphocyte subsets mitochondrial parameters among distinct groups were analyzed, and the association between hemodialysis and the aforementioned mitochondrial parameters was investigated using multiple linear regression analysis.
Results
A total of 250 patients were enrolled (153 hemodialysis and 97 pre‐dialysis). Compared with the pre‐dialysis group, the hemodialysis group had significantly lower white blood cell count (5.62 ± 1.63 vs. 6.49 ± 1.93 × 10 3 /mm 3 , p < 0.001) and neutrophil percentage (67.43 ± 8.10 vs. 70.73 ± 9.41%, p = 0.004), but a higher lymphocyte percentage (20.13 ± 6.39 vs. 17.73 ± 7.05%, p = 0.007). CD45+ lymphocyte percentage was also significantly higher in the hemodialysis group(20.13 ± 7.15 vs. 17.74 ± 7.28, p = 0.011), whereas the MM of CD3+, CD4+, and CD8+ T lymphocytes (2.66 ± 1.03 vs. 3.18 ± 1.45, p = 0.001; 2.96 ± 1.17 vs. 3.56 ± 1.53, p = 0.001; 2.28 ± 1.22 vs. 2.81 ± 1.64, p = 0.007, respectively), and the MMP‐Low% of these T lymphocytes (21.86 ± 10.60 vs. 26.97 ± 11.76, p = 0.001; 15.53 ± 9.78 vs. 20.66 ± 10.42, p < 0.001; 31.12 ± 13.25 vs. 35.28 ± 15.17, p = 0.024, respectively), were significantly reduced. Among hemodialysis patients, those with dialysis duration > 12 months had significantly lower CD4+ T lymphocytes (455.66 ± 232.80 vs. 375.06 ± 150.99, p = 0.029) and MMP‐Low% of CD3+ (25.17 ± 14.08 vs. 20.25 ± 8.02, p = 0.025), CD4+ (18.30 ± 13.47 vs. 14.18 ± 7.06, p = 0.046), and CD8+ (35.22 ± 16.09 vs. 29.13 ± 11.19, p = 0.019) T lymphocytes than those with ≤ 12 months. Linear regression analysis, after adjusting for multiple covariates, confirmed a significant association between hemodialysis and reduced mitochondrial parameters: decreased MM of CD3+ (0.699), CD4+ (0.735) and CD8+ (0.846) T lymphocytes, and reduced MMP‐Low% of CD3+ (4.374%) and CD4+ (4.630%) T lymphocytes.
Conclusion
T lymphocyte MM and MMP‐Low% differ significantly between hemodialysis and pre‐dialysis ESRD patients, and hemodialysis patients exhibit more pronounced T lymphocyte mitochondrial dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Nephrology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
ORCID-Profile: Xueyan Bian
Förderung
- Medical Science and Technology Project of Zhejiang Province
- Key Research and Development Program of Ningbo
Zitieren
APA
Luo, C., Bao, S., Bian, X., Bao, L., Ji, C., Ma, J., & Huang, J. (2026). Mitochondrial Abnormalities of T Lymphocytes in Patients With Maintenance Hemodialysis. Immunity, Inflammation and Disease, 14(3). https://doi.org/10.1002/iid3.70404
Vancouver
Luo C, Bao S, Bian X, Bao L, Ji C, Ma J, et al. Mitochondrial Abnormalities of T Lymphocytes in Patients With Maintenance Hemodialysis. Immunity, Inflammation and Disease. 2026;14(3). doi:10.1002/iid3.70404
BibTeX
@article{Luo2026,
author = {Luo, Chunlei and Bao, Sizeng and Bian, Xueyan and Bao, Lingling and Ji, Chunyang and Ma, Jianwei and Huang, Jiancheng},
title = {Mitochondrial Abnormalities of T Lymphocytes in Patients With Maintenance Hemodialysis},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {3},
doi = {10.1002/iid3.70404}
}
EUVIMED